These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26210757)

  • 1. The female urinary microbiome in urgency urinary incontinence.
    Pearce MM; Zilliox MJ; Rosenfeld AB; Thomas-White KJ; Richter HE; Nager CW; Visco AG; Nygaard IE; Barber MD; Schaffer J; Moalli P; Sung VW; Smith AL; Rogers R; Nolen TL; Wallace D; Meikle SF; Gai X; Wolfe AJ; Brubaker L;
    Am J Obstet Gynecol; 2015 Sep; 213(3):347.e1-11. PubMed ID: 26210757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incontinence medication response relates to the female urinary microbiota.
    Thomas-White KJ; Hilt EE; Fok C; Pearce MM; Mueller ER; Kliethermes S; Jacobs K; Zilliox MJ; Brincat C; Price TK; Kuffel G; Schreckenberger P; Gai X; Brubaker L; Wolfe AJ
    Int Urogynecol J; 2016 May; 27(5):723-33. PubMed ID: 26423260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence.
    Pearce MM; Hilt EE; Rosenfeld AB; Zilliox MJ; Thomas-White K; Fok C; Kliethermes S; Schreckenberger PC; Brubaker L; Gai X; Wolfe AJ
    mBio; 2014 Jul; 5(4):e01283-14. PubMed ID: 25006228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the relationship between vaginal and urinary microbiomes.
    Komesu YM; Dinwiddie DL; Richter HE; Lukacz ES; Sung VW; Siddiqui NY; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Levy J; Carper B; Gantz MG;
    Am J Obstet Gynecol; 2020 Feb; 222(2):154.e1-154.e10. PubMed ID: 31421123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary microbiome community types associated with urinary incontinence severity in women.
    Carnes MU; Siddiqui NY; Karstens L; Gantz MG; Dinwiddie DL; Sung VW; Bradley M; Brubaker L; Ferrando CA; Mazloomdoost D; Richter HE; Rogers RG; Smith AL; Komesu YM;
    Am J Obstet Gynecol; 2024 Mar; 230(3):344.e1-344.e20. PubMed ID: 38937257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence.
    Thomas-White KJ; Kliethermes S; Rickey L; Lukacz ES; Richter HE; Moalli P; Zimmern P; Norton P; Kusek JW; Wolfe AJ; Brubaker L;
    Am J Obstet Gynecol; 2017 Jan; 216(1):55.e1-55.e16. PubMed ID: 27498309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.
    Amundsen CL; Richter HE; Menefee SA; Komesu YM; Arya LA; Gregory WT; Myers DL; Zyczynski HM; Vasavada S; Nolen TL; Wallace D; Meikle SF
    JAMA; 2016 Oct; 316(13):1366-1374. PubMed ID: 27701661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.
    Komesu YM; Amundsen CL; Richter HE; Erickson SW; Ackenbom MF; Andy UU; Sung VW; Albo M; Gregory WT; Paraiso MF; Wallace D;
    Am J Obstet Gynecol; 2018 Jan; 218(1):111.e1-111.e9. PubMed ID: 29031894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between the urogenital microbiome and surgical treatment response in women undergoing midurethral sling operation for mixed urinary incontinence.
    Richter HE; Carnes MU; Komesu YM; Lukacz ES; Arya L; Bradley M; Rogers RG; Sung VW; Siddiqui NY; Carper B; Mazloomdoost D; Dinwiddie D; Gantz MG;
    Am J Obstet Gynecol; 2022 Jan; 226(1):93.e1-93.e15. PubMed ID: 34297969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity of the midstream urine microbiome in adults with chronic kidney disease.
    Kramer H; Kuffel G; Thomas-White K; Wolfe AJ; Vellanki K; Leehey DJ; Bansal VK; Brubaker L; Flanigan R; Koval J; Wadhwa A; Zilliox MJ
    Int Urol Nephrol; 2018 Jun; 50(6):1123-1130. PubMed ID: 29651696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence.
    Visco AG; Brubaker L; Richter HE; Nygaard I; Paraiso MF; Menefee SA; Schaffer J; Lowder J; Khandwala S; Sirls L; Spino C; Nolen TL; Wallace D; Meikle SF;
    N Engl J Med; 2012 Nov; 367(19):1803-13. PubMed ID: 23036134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of microbiota and host immunologic response on the efficacy of anticholinergic treatment for urgency urinary incontinence.
    Gabriel I; Delaney ML; Au M; Courtepatte A; Bry L; Minassian VA
    Int Urogynecol J; 2023 Dec; 34(12):3041-3050. PubMed ID: 37837459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls.
    Komesu YM; Richter HE; Carper B; Dinwiddie DL; Lukacz ES; Siddiqui NY; Sung VW; Zyczynski HM; Ridgeway B; Rogers RG; Arya LA; Mazloomdoost D; Gantz MG;
    Int Urogynecol J; 2018 Dec; 29(12):1785-1795. PubMed ID: 29909556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder bacterial diversity differs in continent and incontinent women: a cross-sectional study.
    Price TK; Lin H; Gao X; Thomas-White KJ; Hilt EE; Mueller ER; Wolfe AJ; Dong Q; Brubaker L
    Am J Obstet Gynecol; 2020 Nov; 223(5):729.e1-729.e10. PubMed ID: 32380174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.
    Richter HE; Amundsen CL; Erickson SW; Jelovsek JE; Komesu Y; Chermansky C; Harvie HS; Albo M; Myers D; Gregory WT; Wallace D;
    J Urol; 2017 Oct; 198(4):890-896. PubMed ID: 28501541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome Investigation of Urinary
    Putonti C; Thomas-White K; Crum E; Hilt EE; Price TK; Wolfe AJ
    mSphere; 2021 May; 6(3):. PubMed ID: 33980674
    [No Abstract]   [Full Text] [Related]  

  • 17. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial.
    Amundsen CL; Komesu YM; Chermansky C; Gregory WT; Myers DL; Honeycutt EF; Vasavada SP; Nguyen JN; Wilson TS; Harvie HS; Wallace D;
    Eur Urol; 2018 Jul; 74(1):66-73. PubMed ID: 29482936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary bacteria in adult women with urgency urinary incontinence.
    Brubaker L; Nager CW; Richter HE; Visco A; Nygaard I; Barber MD; Schaffer J; Meikle S; Wallace D; Shibata N; Wolfe AJ
    Int Urogynecol J; 2014 Sep; 25(9):1179-84. PubMed ID: 24515544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial.
    Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
    J Urol; 2017 Feb; 197(2S):S216-S223. PubMed ID: 28012773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.